433 related articles for article (PubMed ID: 18501898)
1. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
[TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
4. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
Pepene CE; Ilie IR; Marian I; Duncea I
Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
[TBL] [Abstract][Full Text] [Related]
5. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
[TBL] [Abstract][Full Text] [Related]
6. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.
Talbott EO; Zborowski JV; Boudreaux MY; McHugh-Pemu KP; Sutton-Tyrrell K; Guzick DS
J Clin Endocrinol Metab; 2004 Dec; 89(12):6061-7. PubMed ID: 15579759
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
Soyman Z; Noyan V; Tulmac M; Yucel A; Sagsoz N; Bayrak T; Bayrak A; Cakir E
Fertil Steril; 2011 Mar; 95(3):1067-72. PubMed ID: 21193188
[TBL] [Abstract][Full Text] [Related]
8. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.
Juonala M; Viikari JS; Laitinen T; Marniemi J; Helenius H; Rönnemaa T; Raitakari OT
Circulation; 2004 Nov; 110(18):2918-23. PubMed ID: 15505080
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters.
Pamuk BO; Torun AN; Kulaksizoglu M; Ertugrul D; Ciftci O; Kulaksizoglu S; Yildirim E; Demirag NG
Fertil Steril; 2010 Mar; 93(4):1227-33. PubMed ID: 19108830
[TBL] [Abstract][Full Text] [Related]
10. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?
Soares GM; Vieira CS; Martins WP; Franceschini SA; dos Reis RM; Silva de Sá MF; Ferriani RA
Clin Endocrinol (Oxf); 2009 Sep; 71(3):406-11. PubMed ID: 19094071
[TBL] [Abstract][Full Text] [Related]
11. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
Kaya C; Pabuccu R; Berker B; Satiroglu H
Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of brachial artery flow--mediated dilation and carotid artery intima-media thickness in hypertensive patients].
Savoiu G; Drăgan S; Nicola T; Fira-Mladinescu O; Gorun C; Noveanu L; Tudor A; Muntean D; Mihalas G
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):331-6. PubMed ID: 19295000
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.
Adali E; Yildizhan R; Kurdoglu M; Bugdayci G; Kolusari A; Sahin HG
Fertil Steril; 2010 Jul; 94(2):666-72. PubMed ID: 19368913
[TBL] [Abstract][Full Text] [Related]
15. [Ultrasonographic evaluation of selected parameters of the endothelial function in brachial arteries and IMT measurements in carotid arteries in children with diabetes type 1 using personal insulin pumps--preliminary report].
Tołwińska J; Głowińska-Olszewska B; Urban M; Florys B; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):200-4. PubMed ID: 17020656
[TBL] [Abstract][Full Text] [Related]
16. [Interrelationship between endothelial dysfunction, IMT of the carotid arteries and adhesion molecules in obese hypertensive children and adolescents].
Głowińska-Olszewska B; Tołwińska J; Urban M
Pediatr Endocrinol Diabetes Metab; 2007; 13(1):7-14. PubMed ID: 17493400
[TBL] [Abstract][Full Text] [Related]
17. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.
Pepene CE
Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456
[TBL] [Abstract][Full Text] [Related]
18. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
Brinkworth GD; Noakes M; Moran LJ; Norman R; Clifton PM
BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance.
Karabulut A; Yaylali GF; Demirlenk S; Sevket O; Acun A
Gynecol Endocrinol; 2012 Feb; 28(2):111-4. PubMed ID: 21770828
[TBL] [Abstract][Full Text] [Related]
20. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
